已收录 273175 条政策
 政策提纲
  • 暂无提纲
Simultaneous Estimation of Cilnidipine and Valsartan by RP-HPLC in Tablet Formulation
[摘要] A new high performance liquid chromatography method was developed and validated for the quantitation of Cilnidipine and Valsartan in pharmaceutical formulations. Determination was performed using an ODS C18, 250mm x 4.6mm, 5μm column, a mobile phase containing Methanol: Water (85:15) pH 3 adjusts with ortho-phosphoric acid in isocratic flow rate 1.0 mLmin-1. The method was validated with respect to linearity, precision, robustness, and accuracy. The calibration graphs ranged from 1-5 μg/mL in Cilnidipine and 8-40 μg/mL Valsartan Intra- and interday relative standard deviation values for the standard solutions were 0.5%, 1.64% and 0.22%, 1.62 %. Robustness of relative standard deviation values was 0.334, 0.101 respectively. Total recoveries of Cilnidipine and Valsartan from the laboratory prepared mixtures were 98.94 % and 99.04 % respectively.  
Keywords: cilnidipine, valsartan, ODS, RP-HPLC
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 分析化学
[关键词] cilnidipine;valsartan;ODS;RP-HPLC [时效性] 
   浏览次数:31      统一登录查看全文      激活码登录查看全文